The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab in combination with apatinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: A prospective, single-arm, phase 2 study.
 
Yunlong Cui
No Relationships to Disclose
 
Xu Bao
No Relationships to Disclose
 
Ge Yu
No Relationships to Disclose
 
Huikai Li
No Relationships to Disclose
 
Feng Fang
No Relationships to Disclose
 
Qiang Li
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Qiang Wu
No Relationships to Disclose
 
Lu Chen
No Relationships to Disclose
 
Chen Liu
No Relationships to Disclose
 
Tianqiang Song
No Relationships to Disclose